je.st
news
Vetr Inc. Upgrades Vertex Pharmaceuticals to Buy
2015-11-30 03:30:58| Biotech - Topix.net
The firm currently has a $137.08 price objective on the pharmaceutical company's stock. Vetr 's price objective would indicate a potential upside of 3.02% from the stock's previous close.
Tags: buy
upgrades
pharmaceuticals
vertex
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||